Search
UTSW leads nation’s first study of brief suicide intervention for LGBTQ+ young adults : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/suicide-intervention-for-lgbtq-young-adults.html
UT Southwestern Medical Center will lead the nation’s first study of suicide prevention for LGBTQ+ young adults – a group at higher risk for depression and suicide.
Cardio health decline tied to midlife wealth: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/cardio-health-decline-tied-to-midlife-wealth.html
A relative decline in wealth during midlife increases the likelihood of a cardiac event or heart disease after age 65 while an increase in wealth between ages 50 and 64 is associated with lower cardiovascular risk, according to a new study in JAMA Cardiology.
Cryo-EM imaging of STING protein reveals new binding pocket: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/cryo-em-imaging-of-sting-protein.html
Imaging at near-atomic resolution of a key immune protein commonly known as STING has revealed a previously unrecognized binding site that appears to be pivotal for launching immune attacks, UT Southwestern scientists report in a new study.
UT Southwestern biochemist, molecular biologist named Howard Hughes Medical Institute Investigators: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/howard-hughes-medical-institute-investigators.html
Two UT Southwestern Medical Center researchers – a biochemist and a molecular biologist – are among 33 distinguished scientists nationwide named Howard Hughes Medical Institute (HHMI) Investigators.
UTSW findings advance RAS inhibitors for use in fighting more cancers: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/ras-inhibitors-for-use-in-fighting-more-cancers.html
New findings by UT Southwestern researchers help better understand the how one of the most commonly mutated genetic drivers of cancer passes signals that cause the disease.
UTSW is a founding member of new sickle cell clinical trials network: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/new-sickle-cell-clinical-trials-network.html
In a move that will increase access and efficiency of clinical trials for patients with sickle cell disease.
Enzyme could be major driver of preeclampsia: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/enzyme-could-be-major-driver-of-preeclampsia.html
A new study by UT Southwestern scientists indicates that an enzyme called protein phosphatase 2 (PP2A) appears to be a major driver of preeclampsia, a dangerous pregnancy complication characterized by the development of high blood pressure and excess protein in the urine.
UTSW scientists reveal how vitamin A enters immune cells in the gut: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/how-vitamin-a-enters-immune-cells-in-the-gut.html
Immunologists and geneticists at UT Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines – findings that could offer insight to treat digestive diseases and perhaps help improve the efficacy of some vaccines.
UT Southwestern cancer researchers uncover antitumor mechanisms to help improve radiation therapy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/antitumor-mechanisms-to-help-improve-radiation-therapy.html
An international team of cancer researchers has identified important mechanisms that activate antitumor immune response during radiation therapy
UTSW researchers identify first Beta variant in North Texas amid rise of "variants of concern": Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/first-beta-variant-in-north-texas.html
UT Southwestern Medical Center scientists have identified the first two cases of the Beta variant (B.1.351) of COVID-19 infection in North Texas using next-generation sequencing technologies along with targeted PCR testing.